BRPI0909185A2 - Derivado de vitamina e e seus usos - Google Patents

Derivado de vitamina e e seus usos

Info

Publication number
BRPI0909185A2
BRPI0909185A2 BRPI0909185-8A BRPI0909185A BRPI0909185A2 BR PI0909185 A2 BRPI0909185 A2 BR PI0909185A2 BR PI0909185 A BRPI0909185 A BR PI0909185A BR PI0909185 A2 BRPI0909185 A2 BR PI0909185A2
Authority
BR
Brazil
Prior art keywords
vitamin
derivative
Prior art date
Application number
BRPI0909185-8A
Other languages
English (en)
Inventor
Philip J Bromley
Original Assignee
Virun Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virun Inc filed Critical Virun Inc
Publication of BRPI0909185A2 publication Critical patent/BRPI0909185A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
BRPI0909185-8A 2008-03-20 2009-03-20 Derivado de vitamina e e seus usos BRPI0909185A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7039208P 2008-03-20 2008-03-20
US13240908P 2008-06-16 2008-06-16
PCT/US2009/001774 WO2009117151A2 (en) 2008-03-20 2009-03-20 Compositions containing non-polar compounds

Publications (1)

Publication Number Publication Date
BRPI0909185A2 true BRPI0909185A2 (pt) 2015-08-25

Family

ID=41091456

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909185-8A BRPI0909185A2 (pt) 2008-03-20 2009-03-20 Derivado de vitamina e e seus usos

Country Status (7)

Country Link
US (2) US8765661B2 (pt)
EP (1) EP2268274B1 (pt)
CN (2) CN102036661B (pt)
BR (1) BRPI0909185A2 (pt)
CA (1) CA2715018C (pt)
MX (1) MX2010010214A (pt)
WO (1) WO2009117151A2 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906140B2 (en) 2004-06-17 2011-03-15 Virun, Inc. Compositions for mucosal delivery of agents
BRPI0909185A2 (pt) 2008-03-20 2015-08-25 Virun Inc Derivado de vitamina e e seus usos
MX2010010050A (es) * 2008-03-20 2011-03-15 Virun Inc Star Emulsiones que incluyen un derivado de polietilen glicol de tocoferol.
SA109300195B1 (ar) 2008-03-28 2013-04-20 Astrazeneca Ab تركيبة صيدلانية جديدة مضادة للسرطان
US8337931B2 (en) * 2008-06-23 2012-12-25 Virun, Inc. Compositions containing non-polar compounds
ES2661812T3 (es) 2009-10-16 2018-04-04 Mochida Pharmaceutical Co., Ltd. Composiciones
US9656985B2 (en) * 2009-12-01 2017-05-23 Mycell Technologies, Llc Surfactant-enabled transition metal-catalyzed chemistry
EP2563164B1 (en) 2010-03-23 2016-06-29 Virun, Inc. Nanoemulsion including sucrose fatty acid ester
WO2011143229A2 (en) * 2010-05-10 2011-11-17 J3H, Inc. Lipid compositions and structured lipids containing phospholipids, oral formulations containing the same and methods of making the same
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
KR101643259B1 (ko) * 2010-07-26 2016-07-27 후지필름 가부시키가이샤 유지 함유 조성물 및 그것을 포함하는 경구제제
FR2963561B1 (fr) * 2010-08-03 2013-04-12 Pf Medicament Composition pharmaceutique contenant un extrait de serenoa repens
BR112013005517B1 (pt) 2010-09-07 2018-08-14 Dsm Nutritional Products Ag emulsão comestível, bebida compreendendo a mesma e método para produzir uma emulsão
US20120177631A1 (en) * 2011-01-10 2012-07-12 Morteza Naghavi Composition for Health Promoting Compounds
CA2863544C (en) 2012-02-10 2019-03-26 Virun, Inc. Beverage compositions containing non-polar compounds
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
HK1220872A1 (zh) 2013-03-15 2017-05-19 Virun, Inc. 维生素e水溶性衍生物制剂及包含其的组合物
CN103461487A (zh) * 2013-08-02 2013-12-25 张释文 含有植物甾醇的酸奶及其制备方法
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
CN104187627B (zh) * 2014-08-11 2016-03-02 无限极（中国）有限公司 一种降血脂组合物及其在制备具有降血脂功能的保健食品中的应用
WO2016044813A1 (en) * 2014-09-18 2016-03-24 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
WO2016044805A1 (en) 2014-09-18 2016-03-24 Virun, Inc. Soft gel compositions and pre-gel concentrates
GB2556841B (en) 2015-09-18 2019-04-10 Virun Inc Emulsion compositions comprising mucoadhesive proteins and agents that degrade in water
WO2017140376A1 (en) * 2016-02-19 2017-08-24 Symrise Ag Consumable emulsion
WO2018054265A1 (zh) * 2016-09-20 2018-03-29 张碧婷 亲水性脂类组合物的包装组合物，其制备及调配方法和应用
CN107594506A (zh) * 2016-09-20 2018-01-19 福建奥正投资发展有限公司 亲水性脂类组合物与水基液体的组合，其制备及调配方法和应用
CN107812194A (zh) * 2016-10-07 2018-03-20 福建奥正投资发展有限公司 亲水性的脂类组合物，其制备及调配方法和组合使用
WO2018174938A1 (en) 2017-03-23 2018-09-27 Virun, Inc. Stable dry powders and emulsions containing probiotics and mucoadhesive protein
TWI736754B (zh) * 2017-04-03 2021-08-21 大江生醫股份有限公司 含有植物萃取物之組成物其於促進膠原蛋白增生之用途
CN107568731B (zh) * 2017-10-19 2020-09-29 李宏 一种辅酶q10鱼油纳米乳液及其制备方法与应用
US11465107B2 (en) * 2019-01-31 2022-10-11 Hong Ngoc Thi Dang Process for producing a nano omega-3 microemulsion system
US12653782B2 (en) 2019-09-12 2026-06-16 Nulixir Inc. Controlled release concentrate and suspensions including the same
US20230049050A1 (en) * 2019-12-18 2023-02-16 National Research Council Of Canada Emulsions of bioactive lipophilic compounds including oils
US11162136B1 (en) 2020-04-15 2021-11-02 Enumerix, Inc. Systems and methods for generation of emulsions with suitable clarity with applications of use
WO2022187684A1 (en) 2021-03-05 2022-09-09 Enumerix, Inc. Systems and methods for generating droplets and performing digital analyses
US12540948B2 (en) 2021-03-05 2026-02-03 Countable Labs, Inc. Systems and methods for generating droplets and performing digital analyses
WO2022256612A1 (en) 2021-06-04 2022-12-08 Enumerix, Inc. Compositions, methods, and systems for single cell barcoding and sequencing
US12252745B2 (en) 2021-09-02 2025-03-18 Enumerix, Inc. Detection and digital quantitation of multiple targets
EP4453246A4 (en) 2021-12-20 2025-12-24 Countable Labs Inc DIGITAL DETECTION AND QUANTIFICATION OF MULTIPLE TARGETS

Family Cites Families (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680749A (en) * 1951-12-01 1954-06-08 Eastman Kodak Co Water-soluble tocopherol derivatives
US3102078A (en) * 1961-01-13 1963-08-27 Eastman Kodak Co Water-dispersible vitamin preparations
US3538119A (en) 1967-12-26 1970-11-03 Eastman Kodak Co Catalytic process for converting tocopherol to tocopheryl mono succinate
BR8007911A (pt) * 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
EP0069715B1 (en) * 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
US4665204A (en) * 1985-06-27 1987-05-12 Henkel Corporation Diester derivatives of tocopherol
AU591152B2 (en) * 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
US4835002A (en) * 1987-07-10 1989-05-30 Wolf Peter A Microemulsions of oil in water and alcohol
US4867986A (en) * 1987-07-17 1989-09-19 Pharmachem Laboratories, Inc. Dry stabilized microemulsified omega-three acid-containing oils
US6193793B1 (en) * 1988-01-28 2001-02-27 Howard W. Long Asphaltic compositions and uses therefor
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
SK280968B6 (sk) * 1990-03-02 2000-10-09 Glaxo Group Limited Balenie medikamentu na použite v inhalačnom prístroji
WO1991017985A1 (en) * 1990-05-23 1991-11-28 Lipogenics, Inc. Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds
US5234695A (en) * 1990-07-24 1993-08-10 Eastman Kodak Company Water dispersible vitamin E composition
US5179122A (en) * 1991-02-11 1993-01-12 Eastman Kodak Company Nutritional supplement containing vitamin e
US5167950A (en) 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
US5337740A (en) * 1991-08-01 1994-08-16 New England Pharmaceuticals, Inc. Inhalation devices
EP0543417A1 (en) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
US5239993A (en) * 1992-08-26 1993-08-31 Glaxo Inc. Dosage inhalator providing optimized compound inhalation trajectory
US5415162A (en) * 1994-01-18 1995-05-16 Glaxo Inc. Multi-dose dry powder inhalation device
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
EP0825849A1 (en) 1995-05-19 1998-03-04 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
GB9519468D0 (en) * 1995-09-23 1995-11-22 Smithkline Beecham Plc Novel process
US5593682A (en) * 1995-12-29 1997-01-14 Eastman Chemical Company Skin treating composition
JP2001523221A (ja) * 1996-09-01 2001-11-20 ファーモス コーポレイション 親油性物質の促進された生物学的利用能のための固形共沈物
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US5798333A (en) * 1996-09-17 1998-08-25 Sherman; Bernard C. Water-soluble concentrates containing cyclosporins
TW371619B (en) * 1996-10-07 1999-10-11 Dsm Ip Assets Bv Vitamin preparations for beverage applications
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
FR2763336B1 (fr) * 1997-05-14 1999-08-06 Lvmh Rech Esters de tocopherol et leurs utilisations en cosmetique et pharmacie
US6284268B1 (en) * 1997-12-10 2001-09-04 Cyclosporine Therapeutics Limited Pharmaceutical compositions containing an omega-3 fatty acid oil
ID25908A (id) 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6087353A (en) 1998-05-15 2000-07-11 Forbes Medi-Tech Inc. Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
DE69935946T2 (de) 1998-06-24 2007-09-06 Dsm Ip Assets B.V. Vitaminpulver zur verwendung für getränke
NO984896D0 (no) 1998-10-21 1998-10-21 Marine Lipids As FremgangsmÕte ved separering av lipider og proteiner fra biologisk materiale
EP1137403B1 (en) * 1998-12-11 2009-03-11 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
FR2787325B1 (fr) * 1998-12-17 2001-01-26 Oreal Nanoemulsion a base d'esters gras de sorbitan oxyethylenes ou non oxyethylenes, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US20080070981A1 (en) * 2000-02-23 2008-03-20 Henryk Borowy-Borowski Water-soluble compositions of bioactive lipophilic compounds
US6632443B2 (en) * 2000-02-23 2003-10-14 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US6045826A (en) * 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6982281B1 (en) * 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB9916537D0 (en) 1999-07-14 1999-09-15 Univ Hull Culture of microorganisms for the synthesis of a polyunsaturated fatty acid
AU783656B2 (en) * 1999-09-02 2005-11-24 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
BR0013720A (pt) 1999-09-02 2002-07-23 Nostrum Pharmaceuticals Inc Formulação em pelota de liberação controlada
US6534085B1 (en) * 1999-09-23 2003-03-18 Bioresponse L.L.C. Phytochemicals for promoting weight loss
WO2001032031A2 (en) 1999-11-04 2001-05-10 Monsanto Technology Llc Cholesterol reducing sterol compositions, preparation and method of use
US6391370B1 (en) * 1999-11-12 2002-05-21 Kraft Foods, Inc. Micromilling plant sterols and emulsifiers
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US20050037073A1 (en) * 2000-01-13 2005-02-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
GB2359321B (en) * 2000-02-19 2003-10-29 Robert Yates Safety gate
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US6416793B1 (en) * 2000-07-11 2002-07-09 Bioresponse, L.L.C. Formulations and use of controlled-release indole alkaloids
US6441050B1 (en) 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
US20030165572A1 (en) 2000-09-01 2003-09-04 Nicolas Auriou Water-dispersible encapsulated sterols
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
SK3232003A3 (en) * 2000-09-20 2004-02-03 Nycomed Pharma As Preparation of vitamin emulsions and concentrates thereof
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
CN1450863A (zh) * 2000-11-03 2003-10-22 孟山都技术有限公司 降低胆固醇的甾醇组合物、制备和使用方法
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
GB2377455A (en) * 2001-02-09 2003-01-15 Univ Hull Method of culturing crypthecodinium cohnii
US6455512B1 (en) * 2001-03-05 2002-09-24 Tic Gums, Inc. Water-soluble esterified hydrocolloids
WO2002076970A2 (en) 2001-03-23 2002-10-03 Sonus Pharmaceuticals, Inc. Tocopherol succinate derivatives and compositions
US6989171B2 (en) 2001-04-02 2006-01-24 Pacifichealth Laboratories, Inc. Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
WO2002085335A1 (en) * 2001-04-18 2002-10-31 Nostrum Pharmaceuticals Inc. A novel coating for a sustained release pharmaceutical composition
DE20122900U1 (de) * 2001-07-12 2009-12-03 Aquanova Ag Ubichinon Konzentrat
EP1435910B9 (en) 2001-10-19 2010-02-03 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
CN100391464C (zh) * 2001-12-03 2008-06-04 诺瓦西股份有限公司 含活性维生素d化合物的药物组合物
US6870077B2 (en) * 2002-01-30 2005-03-22 Edward O. Kenaschuk High linolenic acid flax
US7182950B2 (en) * 2002-06-12 2007-02-27 Nutralease Ltd. Nano-sized self-assembled liquid dilutable vehicles
US20060165735A1 (en) * 2002-06-18 2006-07-27 Abril Jesus R Stable emulsions of oils in aqueous solutions and methods for producing same
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
CA2414763A1 (en) * 2002-12-19 2004-06-19 Aquanova German Solubilisate Technologies (Agt) Gmbh Tocopherol concentrates and method for producing same
US20040219274A1 (en) 2003-04-29 2004-11-04 Cook Phillip Michael Beverages containing water-soluble vitamin E
EP1622467A1 (en) 2003-05-05 2006-02-08 Denofa AS Fish oils with an altered fatty acid profile, method of producing same and their use
US20050092969A1 (en) * 2003-10-08 2005-05-05 Kaneka Corporation Method of stabilizing compound having quinone skeleton and stabilized composition
US20050163828A1 (en) 2003-10-27 2005-07-28 Bernard Bobby L. Tocopheryl polyethylene glycol succinate articles and process for preparing TPGS articles
CA2543722C (en) * 2003-10-29 2011-01-04 Sonus Pharmaceuticals, Inc. Tocopherol-modified therapeutic drug compounds
US7790190B2 (en) * 2004-03-20 2010-09-07 Yasoo Health, Inc. Aqueous emulsions of lipophile solubilized with vitamin E TPGS and linoleic acid
US20090189304A1 (en) 2004-04-21 2009-07-30 Friedmann Thomas E Encapsulation of oils by coacervation
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
US7906140B2 (en) 2004-06-17 2011-03-15 Virun, Inc. Compositions for mucosal delivery of agents
US20060051462A1 (en) * 2004-09-03 2006-03-09 Wang Jimmy X Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients
US20060165769A1 (en) * 2004-09-30 2006-07-27 Hyatt John A Pharmaceutical formulations containing vitamin E TPGS molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations
US20060088558A1 (en) * 2004-10-26 2006-04-27 Robert Jandzinski Vitamin E TPGS fluid concentrate comprising a low percentage of water
US8961958B2 (en) 2004-11-16 2015-02-24 Bioavailability, Inc High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use
AU2005309808A1 (en) 2004-11-24 2006-06-01 Merck & Co., Inc. Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
US20060222716A1 (en) 2005-04-01 2006-10-05 Joseph Schwarz Colloidal solid lipid vehicle for pharmaceutical use
JP2008534619A (ja) 2005-04-01 2008-08-28 ザイムス， エルエルシー ＣｏＱ１０を送達システムとして使用する皮膚強化
CN101232871A (zh) * 2005-08-03 2008-07-30 伊士曼化工公司 生育酚聚乙二醇琥珀酸酯粉末及其制备方法
WO2007026271A1 (en) * 2005-09-02 2007-03-08 Firmenich Sa Clear flavor microemulsions comprising sugar esters of fatty acids
US9743680B2 (en) * 2005-10-14 2017-08-29 Wild Flavors, Inc. Microemulsions for use in food and beverage products
CA2626579A1 (en) * 2005-10-25 2007-05-03 Abbott Laboratories Formulation comprising a drug of low water solubility and method of use thereof
US20070104778A1 (en) * 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
PT1903866E (pt) * 2005-11-07 2016-06-09 Murty Pharmaceuticals Inc Distribuição melhorada de tetra-hidrocanabinol
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
US8309156B2 (en) * 2005-12-20 2012-11-13 Pharmachem Laboratories, Inc. Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high HLB emulsifiers
AR059012A1 (es) 2006-01-13 2008-03-05 Aker Biomarine Asa Extractos derivados del krill
WO2007109605A2 (en) * 2006-03-20 2007-09-27 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions
JP2009530415A (ja) * 2006-03-20 2009-08-27 バーテックス ファーマシューティカルズ インコーポレイテッド 医薬組成物
MX2008012844A (es) 2006-04-06 2009-01-19 Activbiotics Pharma Llc Composiciones farmaceuticas y usos de ellas.
EP2031985A2 (en) 2006-06-23 2009-03-11 The Procter and Gamble Company Concentrated omega-3 fatty acids and mixtures containing them
US20090018186A1 (en) * 2006-09-06 2009-01-15 The Coca-Cola Company Stable beverage products comprising polyunsaturated fatty acid emulsions
EP2109371B1 (en) 2006-09-25 2012-10-17 COMSTOCK, Bob Process for solubilization of flavor oils
CA2677253C (en) 2007-02-01 2015-06-30 National Research Council Of Canada Formulations of lipophilic bioactive molecules
WO2008116021A1 (en) * 2007-03-19 2008-09-25 Zymes, Llc Organoleptic compounds with enhanced properties
WO2008134766A1 (en) 2007-04-30 2008-11-06 Zymes, Llc Applications of ubiquinones and ubiquinols
KR100849537B1 (ko) * 2007-07-04 2008-07-31 유효경 코엔자임 큐텐의 나노에멀젼 조성물
KR20100068265A (ko) 2007-08-29 2010-06-22 에이전시 포 사이언스, 테크놀로지 앤드 리서치 미용 및 약제용의, 에센셜 오일을 함유하는 당질계 계면활성제 마이크로에멀젼
BRPI0909185A2 (pt) 2008-03-20 2015-08-25 Virun Inc Derivado de vitamina e e seus usos
DE102008015366A1 (de) 2008-03-20 2009-09-24 Merck Patent Gmbh Lyophilisierte Nanoemulsion
MX2010010050A (es) 2008-03-20 2011-03-15 Virun Inc Star Emulsiones que incluyen un derivado de polietilen glicol de tocoferol.
EP2273977A2 (en) * 2008-04-08 2011-01-19 Zymes, LLC Dried formulations
US8337931B2 (en) 2008-06-23 2012-12-25 Virun, Inc. Compositions containing non-polar compounds
AU2009271437A1 (en) 2008-07-15 2010-01-21 Comstock, Robert Lawrence Mr Improved emulsifying system for nutraceutical composition
US20100041622A1 (en) * 2008-08-13 2010-02-18 Bromley Philip J Compositions containing aminoalkanes and aminoalkane derivatives
WO2011060084A1 (en) * 2009-11-10 2011-05-19 MyCell Holdings Limited Stabilized formulations of fatty acids
EP2563164B1 (en) * 2010-03-23 2016-06-29 Virun, Inc. Nanoemulsion including sucrose fatty acid ester
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
CA2863544C (en) 2012-02-10 2019-03-26 Virun, Inc. Beverage compositions containing non-polar compounds
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
WO2016044813A1 (en) 2014-09-18 2016-03-24 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
WO2016044805A1 (en) 2014-09-18 2016-03-24 Virun, Inc. Soft gel compositions and pre-gel concentrates
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same

Also Published As

Publication number Publication date
WO2009117151A2 (en) 2009-09-24
HK1148686A1 (en) 2011-09-16
EP2268274A2 (en) 2011-01-05
CN103190631A (zh) 2013-07-10
US20140242055A1 (en) 2014-08-28
WO2009117151A3 (en) 2010-05-20
EP2268274B1 (en) 2012-05-16
US9788564B2 (en) 2017-10-17
US8765661B2 (en) 2014-07-01
HK1187213A1 (zh) 2014-04-04
MX2010010214A (es) 2010-12-21
CN102036661B (zh) 2016-12-28
CN103190631B (zh) 2016-01-20
CA2715018A1 (en) 2009-09-24
US20090297491A1 (en) 2009-12-03
CN102036661A (zh) 2011-04-27
CA2715018C (en) 2012-11-13

Similar Documents

Publication Publication Date Title
PT2473528E (pt) Formulações estáveis de polipéptidos e seus usos
BRPI0910746A2 (pt) reticuladores e seus usos
BRPI0921862A2 (pt) inibidores de raf e seus usos
BRPI1016150A2 (pt) compostos heterocíclicos e seus usos.
BR112012000660A2 (pt) compostos heterociclos e seus usos
BRPI0908853A2 (pt) composto oligopeptídicos e seus usos
BRPI0817881A2 (pt) Compostos orgânicos e seus usos
BR112013006272A2 (pt) compostos de piridina e seus usos
BRPI0913640A2 (pt) substâncias policrômicas e seus usos
BRPI0920927A2 (pt) derivados de azaquinolinona e usos dos mesmos
BRPI1011404A2 (pt) mutantes e usos dos mesmos
BRPI1013642A2 (pt) derivado de triazina e composição farmacêutica compreendendo o mesmo
BRPI0718182A2 (pt) Oligorribonucleotídeos e seus usos.
BRPI0809103A2 (pt) composições de magnésio e seus usos
BRPI0813244A2 (pt) Compostos e seus usos 708
BR112012008074A2 (pt) derivados de piridina e pirazina como moduladores de proteína quinase
DK2361116T3 (da) Bestrålingsindretning
BRPI1010239A2 (pt) endoglucanases aprimoradas, derivados e seus usos
BRPI1016117A2 (pt) derivados de isoxazol-isoxazol e isoxasol-isotiazol.
BRPI0906498A2 (pt) Anticorpo ron e seus usos
BR112013012129A2 (pt) composições de adesivos e seus usos
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI0710878A2 (pt) Compostos orgânicos e seus usos
BRPI0817234A2 (pt) Análogos de azacitidina e seus usos
BR112012010242A2 (pt) derivados de heteroarilpiperidina e heteroarilpiperazina

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: VIRUN, INC. (DELAWARE) (US)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements